Feature Story
Aidar Health Receives CE Mark Approval for MouthLab, a Medical Tricorder Optimized for Rapid Health Assessment
Feb. 16, 2021 -- MouthLab is the world’s first rapid health assessment device that measures more than 10 vital health parameters in just 60 seconds, enabling a more personalized, data-driven, daily health monitoring tool for users and a real-time surveillance system for physicians. press release
More Client & Industry News
Partner Alio Featured in the GIANT Healthy Innovators Live TV Event
Jan. 14, 2021 -- GIANT Health runs a weekly live TV programme featuring passionate personalities in the world of health tech innovation. iO life science partner Alio's Founder and CEO, David Kuraguntla, is invited as a guest panelist in season 3, episode 1.
watch episode
iO Portfolio Companies Showcased at Largest Physician Innovation Event
Jan. 8-10, 2021 -- IGS2021 (InnovatorMD Global Summit) is an attempt to showcase physician innovators' work from around the world, inspire others to learn, and ignite innovation in healthcare. iO portfolio companies OncoDisc, Otomagnetics and Surgical Automations are among the innovators to participate.
event page
GS Lab and iO life science Partner to Accelerate Patient Centric Medical Device Development
Dec. 15, 2020 -- GS Lab, an emerging leader in the medical devices industry, and a leader in product engineering, today announced it is teaming up with iO life science, a design and development firm dedicated to transforming lives through the innovation of smart, connected, patient-centric devices.
press release
Nov. 10, 2020
Alio Introduces Series of Studies for Clinical-Grade Noninvasive Wearable
Oct. 28, 2020
How an Implantable Dialysis Device May Extend Life for People with Kidney Failure
Oct. 13, 2020
Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer
Sep. 21, 2020
Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant
Aug. 6, 2020
Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology
